-+ 0.00%
-+ 0.00%
-+ 0.00%

VivoSim Labs plans rat liver model expansion for NAMkind platform

PUBT·09/01/2026 12:06:42
Listen to the news
VivoSim Labs plans rat liver model expansion for NAMkind platform
  • VivoSim Labs plans to develop a rat liver model to expand its NAMkind human liver platform for preclinical liver toxicology.
  • Paired rat-human models target species-translation risk, helping assess whether rat liver findings are relevant to humans.
  • Validation will use compounds with known rat-human differences in liver toxicity.
  • Strategy aims to reduce premature program termination, improve decision-making on advancing or modifying drug candidates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VivoSim Labs Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010805PRIMZONEFULLFEED9819125) on September 01, 2026, and is solely responsible for the information contained therein.